Skip to main content
logo
BL Pharmtech Corp. (KOSDAQ:065170)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,990.00
+53.00 (2.74%)
At close: Aug 24, 2026

BL Pharmtech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-15,189-16,778-5,706-148.85-13,903-20,211
Depreciation & Amortization
486.44556.32852.35848.1900.553,448
Loss (Gain) From Sale of Assets
-4.23-2.79-78.66-52.54--3,032
Asset Writedown & Restructuring Costs
--9502,9005,15116,238
Loss (Gain) From Sale of Investments
3,2623,262180.06--283.8-67.11
Loss (Gain) on Equity Investments
10,78410,6511,505468.95358.97-
Stock-Based Compensation
151.78152.08-5.320.439.4819.22
Provision & Write-off of Bad Debts
-3,522-2,584-593.47-124.1465.09191.72
Other Operating Activities
2,9113,007140.483,8234,9467,437
Change in Accounts Receivable
-884.28-188.69130.62-1,3131,083-325.77
Change in Inventory
718.041,090854.117,741-3,320314.38
Change in Accounts Payable
-57.23-88.31-674.821,514-2,9061,776
Change in Other Net Operating Assets
-1,137638.85-591.29-559.25-8,182-2,691
Operating Cash Flow
-2,480-283.76-3,0377,992-10,9983,097
Operating Cash Flow Growth
------46.64%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---1,166-312.07-1,708-587.15
Sale of Property, Plant & Equipment
---161.4-6,257
Divestitures
11-26,264--
Sale (Purchase) of Intangibles
-5.7-7.11-1,000-1.5-13.94-291.27
Investment in Securities
1,851-39.333,714-10,817-1,459-7,102
Other Investing Activities
6,5536,553-8,0510-192.022,045
Investing Cash Flow
8,5556,657-6,44715,294-3,374321.64

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--1,00024,38811,388-
Long-Term Debt Issued
-1,040-6,29950016,373
Total Debt Issued
1,0401,0401,00030,68711,88816,373
Short-Term Debt Repaid
----24,855-12,721-1,695
Long-Term Debt Repaid
--4,071-389.23-23,533-1,489-8,829
Total Debt Repaid
-4,081-4,071-389.23-48,389-14,210-10,523
Net Debt Issued (Repaid)
-3,041-3,032610.77-17,702-2,3225,850
Issuance of Common Stock
0-----
Repurchase of Common Stock
--7.66-2---0.38
Other Financing Activities
-1.37-48.192,1290--9.13
Financing Cash Flow
-3,042-3,0882,738-17,702-2,3225,840

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.821.663.01-0.46-35.05113.13
Net Cash Flow
3,0333,287-6,7435,584-16,7289,372

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,480-283.76-4,2037,680-12,7062,510
Free Cash Flow Growth
------
Free Cash Flow Margin
-49.25%-4.36%-47.74%31.31%-56.41%2.97%
Free Cash Flow Per Share
-92.83-10.64-157.64287.73-476.0495.28
Levered Free Cash Flow
1,5952,068-7,7447,260-11,2734,183
Unlevered Free Cash Flow
2,0802,630-7,2258,243-9,8945,803

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
279.97313.54356.191,491930.47925.5
Cash Income Tax Paid
--85.6234.63-39.22-14.29-2.83
Change in Working Capital
-1,3611,452-281.377,382-13,324-926.44